Details for Patent: 11,944,627
Which drugs does patent 11,944,627 protect, and when does it expire?
Patent 11,944,627 protects KOMZIFTI and is included in one NDA.
This patent has nine patent family members in four countries.
Summary for Patent: 11,944,627
| Title: | Methods for treating hematological malignancies and Ewing's sarcoma |
| Abstract: | The present disclosure provides methods for treating hematological malignancies and Ewings sarcoma using menin inhibitors. Compositions for use in these methods are also provided. |
| Inventor(s): | Francis Burrows, Linda V. KESSLER, Liansheng Li, Pingda Ren, Yi Wang, Tao Wu, Jingchuan Zhang |
| Assignee: | Wellspring Biosciences LLC , Kura Oncology Inc |
| Application Number: | US16/494,556 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 11,944,627
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kura | KOMZIFTI | ziftomenib | CAPSULE;ORAL | 220305-001 | Nov 13, 2025 | RX | Yes | Yes | 11,944,627 | ⤷ Start Trial | METHOD OF TREATING ACUTE MYELOID LEUKEMIA | ⤷ Start Trial | ||||
| Kura | KOMZIFTI | ziftomenib | CAPSULE;ORAL | 220305-001 | Nov 13, 2025 | RX | Yes | Yes | 11,944,627 | ⤷ Start Trial | METHOD OF TREATING ACUTE MYELOID LEUKEMIA WITH ZIFTOMENIB OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,944,627
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| China | 110691779 | ⤷ Start Trial | |||
| China | 117298275 | ⤷ Start Trial | |||
| European Patent Office | 3601249 | ⤷ Start Trial | |||
| Japan | 2020514388 | ⤷ Start Trial | |||
| Japan | 2023055735 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
